Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Roche: Partnering and Global Activity




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Roche: Partnering and Global Activity
Released on: December 14, 2009. © PharmaVentures Ltd
Visitors: You are watching a 30 seconds preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
In this episode of PharmaTelevision News Review, Fintan Walton talks with Bardia Akbari, Global Head of Partnering, Inflammation and AutoImmune at Hoffmann-La Roche.

Filmed at AusBiotech 2009, they discuss:

• how Roche differentiates itself from the rest of the pharmaceutical companies
• where Roche is looking to do deals within the world, and its alliances with biotech companies
• what clinical stage products Roche is looking for
• the company’s diagnostics division
• how Roche is working together with personnel from Genentech following Genentech’s acquisition
• Roche’s focus on Asthma, COPD and Rheumatoid Arthritis
• the company’s reason for its Nutley location
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
The company's reason for its Nutley location
Fintan Walton:
Hello and welcome to PharmaTelevision news review here in Melbourne, Australia. On this show I have Bardia Akbari, who is the Global Head of Inflammation and Autoimmune at Roche, welcome.
Bardia Akbari:
Thank you very much for having me.
Fintan Walton:
Bardia Akbari, you are based in Nutley, and as I said you are the Global Head of Partnering for Inflammation and Autoimmune disease.
Bardia Akbari:
Yeah.
Fintan Walton:
Why are you based in Nutley?
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Bardia Akbari
Global Head of Inflammation and Autoimmune
Hoffmann-La Roche
Hoffmann-La Roche is the US prescription pharmaceuticals unit of Roche. The company develops, manufactures, and markets drugs to treat such life-threatening conditions as AIDS, cancer, and heart disease. Other product categories include central nervous system disorders, organ transplant rejection, and skin conditions. Hoffmann-La Roche products include influenza fighter Tamiflu, cancer drug Xeloda, HIVinhibitor (co-marketed with Trimeris), obesity drug Xenical, and hepatitis B-CtherapyPegasys. Hoffmann-La-Roche R&D is focused on oncology and metabolic, CNS, virology, inflammatory, respiratory, and autoimmune diseases.